Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy

ConditionKidney Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche

About this trial

The purpose of this study is to compare to assess the incidence of post-operative complications related to nephrectomy, which occur up to 1 month after the operation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients over 18 ;

Localised kidney cancer ;

Validation of curative treatment at a multidisciplinary consultation meeting;

Partial or total laparoscopic nephrectomy scheduled on an outpatient basis;

Disqualifiers

Emergency intervention ;

Patient not eligible for outpatient treatment;

Long-term curative anti-coagulant treatment ;

Resident more than 100km from the clinic;

Trial population

Adult patients diagnosed with localised kidney cancer, undergoing scheduled surgery for partial or total laparoscopic nephrectomy on an outpatient basis.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Partial or total laparoscopic nephrectomy

    Procedure/Surgery

    Nephrectomy is currently the primary indication for localised kidney cancer. All patients consulting a surgeon at the Clinique de la Sauvegarde for localised kidney cancer, for which surgical excision has been validated by the multidisciplinary consultation meeting and who are eligible for outpatient treatment, will be offered the opportunity to take part in this study during the preoperative consultation.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: cohort of outpatients1 intervention

Trial outcomes

Primary outcomes

1

Incidence of complications

The study will observe the incidence and describe the type, number, severity, duration and frequency of complications that may arise in the immediate post-operative period following ambulatory nephrectomy.

Time frame
1 month

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.